Comparison of the Predicting Value of Neutrophil to high-Density Lipoprotein Cholesterol Ratio and Monocyte to high-Density Lipoprotein Cholesterol Ratio for in-Hospital Prognosis and Severe Coronary Artery Stenosis in Patients with ST-Segment Elevation Acute Myocardial Infarction Following Percutaneous Coronary Intervention: A Retrospective Study

References

• Tsao CW, Aday AW, Almarzooq ZI, et al. Heart Disease and Stroke Statistics-2023 Update: a Report From the American Heart Association. Circulation. 2023;147(8):e93–e621. doi:10.1161/CIR.0000000000001123
   PubMed Web of Science ®Google Scholar
• bank Tw. Toward a Healthy and Harmonious Life in China: Stemming the Rising Tide of Non-Communicable Diseases. World Bank Report; 2014.
   Google Scholar
• Libby P. Inflammation in Atherosclerosis. Arterioscler Thromb Vasc Biol. 2012;32(9):2045–2051. doi:10.1161/atvbaha.108.179705
   PubMed Web of Science ®Google Scholar
• Schaftenaar F, Frodermann V, Kuiper J, Lutgens E. Atherosclerosis: the interplay between lipids and immune cells. Curr Opin Lipidol. 2016;27(3):209–215. doi:10.1097/MOL.0000000000000302
   PubMed Web of Science ®Google Scholar
• Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111(25):3481–3488. doi:10.1161/CIRCULATIONAHA.105.537878
   PubMed Web of Science ®Google Scholar
• Pepine CJ, Nichols WW. The pathophysiology of chronic ischemic heart disease. Clin Cardiol Feb. 2007;30(2 Suppl 1):I4–9. doi:10.1002/clc.20048
   PubMed Web of Science ®Google Scholar
• Silbernagel G, Schottker B, Appelbaum S, et al. High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality. Eur Heart J. 2013;34(46):3563–3571. doi:10.1093/eurheartj/eht343
   PubMed Web of Science ®Google Scholar
• Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79(1):8–15. doi:10.1161/01.cir.79.1.8
   PubMed Web of Science ®Google Scholar
• Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 2011;17(11):1410–1422. doi:10.1038/nm.2538
   PubMed Web of Science ®Google Scholar
• Matthias Nahrendorf FKS. Immunology. Neutrophil-macrophage communication in inflammation and atherosclerosis. Science. 2015;349(6245):237. doi:10.1126/science.aac7801
   PubMed Web of Science ®Google Scholar
• Woollard KJ, Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol. 2010;7(2):77–86. doi:10.1038/nrcardio.2009.228
   PubMed Web of Science ®Google Scholar
• Figueiredo ET, Miranda CH. Is the variation in monocyte to high-density lipoprotein cholesterol ratio a predictor of major cardiovascular events after acute coronary syndrome? Braz J Med Biol Res. 2023;55:e12410. doi:10.1590/1414-431X2022e12410
   PubMed Web of Science ®Google Scholar
• Villanueva DLE, Tiongson MD, Ramos JD, Llanes EJ. Monocyte to High-Density Lipoprotein Ratio (MHR) as a predictor of mortality and Major Adverse Cardiovascular Events (MACE) among ST Elevation Myocardial Infarction (STEMI) patients undergoing primary percutaneous coronary intervention: a meta-analysis. Lipids Health Dis. 2020;19(1):55. doi:10.1186/s12944-020-01242-6
   PubMed Web of Science ®Google Scholar
• Chen Y, Jiang D, Tao H, Ge P, Duan Q. Neutrophils to high-density lipoprotein cholesterol ratio as a new prognostic marker in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a retrospective study. BMC Cardiovasc Disord. 2022;22(1):434. doi:10.1186/s12872-022-02870-9
   PubMed Web of Science ®Google Scholar
• Boateng S, Sanborn T. Acute myocardial infarction. Dis Mon. 2013;59(3):83–96. doi:10.1016/j.disamonth.2012.12.004
   PubMed Web of Science ®Google Scholar
• Stein R, Ferrari F, Scolari F. Genetics, Dyslipidemia, and Cardiovascular Disease: new Insights. Curr Cardiol Rep. 2019;21(8):67.
   PubMed Web of Science ®Google Scholar
• Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014;114(12):1852–1866. doi:10.1161/CIRCRESAHA.114.302721
   PubMed Web of Science ®Google Scholar
• Swystun LL, Liaw PC. The role of leukocytes in thrombosis. Blood. 2016;128(6):753–762. doi:10.1182/blood-2016-05-718114
   PubMed Web of Science ®Google Scholar
• Silvestre-Roig C, Braster Q, Ortega-Gomez A, Soehnlein O. Neutrophils as regulators of cardiovascular inflammation. Nat Rev Cardiol. 2020;17(6):327–340. doi:10.1038/s41569-019-0326-7
   PubMed Web of Science ®Google Scholar
• Drechsler M, Megens RT, van Zandvoort M, Weber C, Soehnlein O. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation. 2010;122(18):1837–1845. doi:10.1161/CIRCULATIONAHA.110.961714
   PubMed Web of Science ®Google Scholar
• Pircher J, Czermak T, Ehrlich A, et al. Cathelicidins prime platelets to mediate arterial thrombosis and tissue inflammation. Nat Commun. 2018;9(1):1523. doi:10.1038/s41467-018-03925-2
   PubMedGoogle Scholar
• Yonggang Ma AY, Merry L. Neutrophil roles in left ventricular remodeling following myocardial infarction. Fibrogenesis Tissue Repair. 2013;6:11. doi:10.1186/1755-1536-6-11
   PubMedGoogle Scholar
• Daseke MJ, Valerio FM, Kalusche WJ, Ma Y, DeLeon-Pennell KY, Lindsey ML. Neutrophil proteome shifts over the myocardial infarction time continuum. Basic Res Cardiol. 2019;114(5):678.
   Web of Science ®Google Scholar
• Soehnlein O, Weber C, Lindbom L. Neutrophil granule proteins tune monocytic cell function. Trends Immunol. 2009;30(11):538–546. doi:10.1016/j.it.2009.06.006
   PubMed Web of Science ®Google Scholar
• Soehnlein O, Zernecke A, Eriksson EE, et al. Neutrophil secretion products pave the way for inflammatory monocytes. Blood. 2008;112(4):1461–1471. doi:10.1182/blood-2008-02-139634
   PubMed Web of Science ®Google Scholar
• Ionita MG, van den Borne P, Catanzariti LM, et al. High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions. Arterioscler Thromb Vasc Biol. 2010;30(9):1842–1848. doi:10.1161/ATVBAHA.110.209296
   PubMed Web of Science ®Google Scholar
• Hassan M, Philip P. CANHEART: is HDL cholesterol a cardiovascular specific risk factor? Glob Cardiol Sci Pract. 2016;2016(4):e201634. doi:10.21542/gcsp.2016.34
   PubMedGoogle Scholar
• Voight BF, Peloso GM, Orho-Melander M, et al. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study. Lancet. 2012;380(9841):572–580. doi:10.1016/s0140-6736(12)60312-2
   PubMed Web of Science ®Google Scholar
• Rosenson RS, Brewer HB Jr, Ansell BJ, et al. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol. 2016;13(1):48–60. doi:10.1038/nrcardio.2015.124
   PubMed Web of Science ®Google Scholar
• Maiolino G, Rossitto G, Caielli P, Bisogni V, Rossi GP, Calo LA. The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. Mediators Inflamm. 2013;2013:714653. doi:10.1155/2013/714653
   PubMed Web of Science ®Google Scholar
• Parthasarathy JB S, Fong LG. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta. 1990.
   Google Scholar
• Murphy AJ, Woollard KJ, Hoang A, et al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol. 2008;28(11):2071–2077. doi:10.1161/ATVBAHA.108.168690
   PubMed Web of Science ®Google Scholar
• Yvan-Charvet L, Pagler T, Gautier EL, et al. ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science. 2010;328(5986):1689–1693. doi:10.1126/science.1189731
   PubMed Web of Science ®Google Scholar
• Acikgoz SK, Acikgoz E, Sensoy B, Topal S, Aydogdu S. Monocyte to high-density lipoprotein cholesterol ratio is predictive of in-hospital and five-year mortality in ST-segment elevation myocardial infarction. Cardiol J. 2016;23(5):505–512. doi:10.5603/CJ.a2016.0026
   PubMed Web of Science ®Google Scholar
• Karatas MB, Canga Y, Ozcan KS, et al. Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention. Am J Emerg Med. 2016;34(2):240–244. doi:10.1016/j.ajem.2015.10.049
   PubMed Web of Science ®Google Scholar
• Wu TT, Zheng YY, Chen Y, Yu ZX, Ma YT, Xie X. Monocyte to high-density lipoprotein cholesterol ratio as long-term prognostic marker in patients with coronary artery disease undergoing percutaneous coronary intervention. Lipids Health Dis. 2019;18(1):180. doi:10.1186/s12944-019-1116-2
   PubMed Web of Science ®Google Scholar